Law, Strategy, and Risk in Commercial Disputes
Blawgletter's friend Sam Simon asked us to visit this morning with the Class Action Committee of the New York State Bar's Antitrust Section, and the chair — whom we also count as a friend — Hollis Salzman gave her okay.
You can see below the remarks we wrote out (plus a Q&A at the end to reflect…
A couple weeks ago, if you found yourself in downtown Philadelphia, you could've stopped in the U.S. courthouse there and seen Blawgletter argue a Rule 23(f) appeal to an impressive panel of the Third Circuit Court of Appeals. The appeal challenges an order certifying a class of Philadelphia-area cable subscribers. Behrend v. Comcast Corp., No.
The Second Circuit last week prescribed death for a class action alleging that Eli Lilly and Company fooled doctors into treating patients with Lily's anti-schizophrenia drug Zyprexa.
The plaintiffs — unions and others that pay all or part of patients' pharmaceutical bills — alleged that Lilly violated the Racketeer-Influenced and Corrupt Organizations Act by hiding and misrepresenting…